Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome.

Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome.

Item
http://www.wikidata.org/entity/Q33408239
Diagnostic yields in solid organ transplant recipients admitted with diarrheaA comprehensive review of the published assays for the quantitation of the immunosuppressant drug mycophenolic acid and its glucuronidated metabolites in biological fluids.Risk Factors of Graft Survival After Diagnosis of Post-kidney Transplant Malignancy: Using Cox Proportional Hazard ModelPharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Mycophenolate revisited.Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy.Clinical outcome of norovirus infection in renal transplant patients.The effect of MMF dose and trough levels on adverse effects in pediatric heart transplant recipients.Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers.High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitis.Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians
P2860

Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome.

Item
http://www.wikidata.org/entity/Q33408239
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Reasons for dose reduction of ...... d its impact on graft outcome.
@ast
Reasons for dose reduction of ...... d its impact on graft outcome.
@en
type
label
Reasons for dose reduction of ...... d its impact on graft outcome.
@ast
Reasons for dose reduction of ...... d its impact on graft outcome.
@en
prefLabel
Reasons for dose reduction of ...... d its impact on graft outcome.
@ast
Reasons for dose reduction of ...... d its impact on graft outcome.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Reasons for dose reduction of ...... d its impact on graft outcome.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698